$29.00
-0.25-0.85%
Pre-Market: 4:36 PM EDT
15 minutes delayed
Comments
Loading...
Castle Biosciences (CSTL) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestCastle Biosciences (NASDAQ:CSTL) Stock Quotes, Forecast and News Summary
Castle Biosciences Stock (NASDAQ: CSTL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Castle Biosciences (CSTL) stock?
You can purchase shares of Castle Biosciences (NASDAQ:CSTL) through any online brokerage.
Who are Castle Biosciences (CSTL) competitors?
Other companies in Castle Biosciences’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Hldgs (NASDAQ:WGS), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and OPKO Health (NASDAQ:OPK).
What is the forecast, or price target, for Castle Biosciences (CSTL) stock?
Castle Biosciences has a consensus price target of $35.36.
What is the current price for Castle Biosciences (CSTL)?
The stock price for Castle Biosciences (NASDAQ: CSTL) is $29 last updated September 24, 2024 at 4:36 PM EDT.
Does Castle Biosciences (CSTL) pay a dividend?
There are no upcoming dividends for Castle Biosciences.
When is Castle Biosciences (NASDAQ:CSTL) reporting earnings?
Castle Biosciences’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Castle Biosciences (CSTL) going to split?
There is no upcoming split for Castle Biosciences.
What sector and industry does Castle Biosciences (CSTL) operate in?
Castle Biosciences is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.